MINCHA PARKER: Open Payments
NPI 1407820020 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 15 payments from 14 companies in 2025. Trend: 2023 $1,901 · 2024 $1,859 · 2025 $1,688
Food & beverage: $1,688
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $242 |
| Exelixis Inc. | 1 | $126 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Abbott Laboratories | 1 | $122 |
| Novo Nordisk Inc | 1 | $121 |
| Merck Sharp & Dohme LLC | 1 | $120 |
| Insulet Corporation | 1 | $117 |
| JAZZ PHARMACEUTICALS INC. | 1 | $107 |
| Amgen Inc. | 1 | $107 |
| KYOWA KIRIN, INC. | 1 | $107 |
Products named: CAPLYTA, CABOMETYX, JEMPERLI, FREESTYLE LIBRE 3, Wegovy, KEYTRUDA, OMNIPOD, ZIIHERA.
Industry payments across KY — which companies pay providers there.
